Guidance Document: Use of a Foreign-sourced Reference Product as a Canadian Reference Product (English, HTML)
Guidance Document: Use of a Foreign-sourced Reference Product as a Canadian Reference Product: English HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-09-01
To provide sponsors of an Abbreviated New Drug Submission or an Abbreviated Extraordinary Use New Drug Submission who are seeking to demonstrate pharmaceutical equivalence and bioequivalence with a reference drug under paragraph (c) of the definition of Canadian reference product (CRP) in C.08.001.1 of the Food and Drug Regulations with guidance on how they may demonstrate that this reference drug is acceptable to the Minister as a CRP.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file